Story perspectives

Study Confirms Rare Myocarditis Risk Post-COVID Vaccination

12/18/2025

Summary

Story summary

A Stanford University–led study finds myocarditis after COVID-19 vaccination is rare, especially in young males, with incidences about 1 in 140,000 after the first dose and 1 in 32,000 after the second.
Symptoms include chest pain and shortness of breath, typically appearing within days of vaccination.
Researchers identify CXCL10 and IFN-gamma as major contributors to the inflammatory process.
The study concludes that vaccination benefits outweigh the risks of myocarditis.

1 of 1

Story summary

A Stanford University–led study finds myocarditis after COVID-19 vaccination is rare, especially in young males, with incidences about 1 in 140,000 after the first dose and 1 in 32,000 after the second.
Symptoms include chest pain and shortness of breath, typically appearing within days of vaccination.
Researchers identify CXCL10 and IFN-gamma as major contributors to the inflammatory process.
The study concludes that vaccination benefits outweigh the risks of myocarditis.